How many patents does
Sepracor have?
patents
625
families
68
granted
168
applications
457
US
183
EP
76
CN
38
WO
31
JP
27
KR
14
RoW
256
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Sepracor
Top ten assignees appearing on patents
2009 - 2018
2009
| sepracor | 88 |
| sunovion pharmaceuticals | 3 |
| seprakor ink. | 2 |
| sunovion pharmaceutical | 1 |
2018
| sunovion pharmaceuticals | 17 |
Sepracor
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| levalbuterol salt | 32 | 2002 |
| phenyl substituted cycloalkylamines as monoamine reuptake inhibitors | 30 | 2007 |
| preparation of chiral amides and amines | 29 | 2006 |
| treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naptha… 🛈 | 27 | 2002 |
| solid forms comprising (-)-o-desmethylvenlafaxine and uses thereof | 26 | 2007 |
| formoterol tartrate process and polymorph | 24 | 2001 |
| triple reuptake inhibitors and methods of their use | 23 | 2008 |
| acetamide stereoisomer | 22 | 2007 |
| pyrrolidine triple reuptake inhibitors | 21 | 2009 |
| cycloalkylamines as monoamine reuptake inhibitors | 21 | 2006 |